Histamine ameliorates anti-glomerular basement membrane antibody-induced glomerulonephritis in rats

Kidney International

Volumn 72, Issue 5, 2007, Pages 608-613

  Tanda, S ^a   Mori, Y ^a   Kimura, T ^a   Sonomura, K ^a   Kusaba, T ^a   Kishimoto, N ^a   Kameyama, H ^a   Tamagaki, K ^a   Okigaki, M ^a   Hatta, T ^a   Sasaki, S ^a   Takeda, K ^a   Sado, Y ^b   Adachi, N ^c   Matsubara, H ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Shigei Medical Research Institute   (Japan)

^c Mabuchi Clinic   (Japan)

Author keywords

Anti GBM glomerulonephritis; Histamine; Macrophages; Rats

Indexed keywords

CHELATING AGENT; CLOZAPINE; DIMAPRIT; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HISTAMINE; HISTAMINERGIC LIGAND; INTERLEUKIN 12; MEPYRAMINE; RANITIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GLOMERULAR STRUCTURE; IMMUNE COMPLEX NEPHRITIS; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY INJURY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; TH1 CELL;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FEMALE; GLOMERULONEPHRITIS; HISTAMINE; IMMUNOSUPPRESSIVE AGENTS; LIGANDS; PROTEINURIA; RATS;

EID: 34548147471     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002370     Document Type: Article

References (30)

1. Tipping PG, Kitching AR, Huang XR et al. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 1997; 27: 530-537.
2. Huang XR, Tipping PG, Shuo L et al. Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int 1997; 51: 94-103.
3. Neale TJ, Tipping PG, Carson SD et al. Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet 1988; 2: 421-424.
4. Holdsworth SR, Kitching AR, Tipping PG. Th1 and Th2T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int 1999; 55: 1198-1216.
5. Kitching AR, Tipping PG, Huang XR et al. Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int 1997; 52: 52-59.
6. Kitching AR, Tipping PG, Timoshanko JR et al. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis. Kidney Int 2000; 57: 518-525.
7. El-Shemi AG, Fujinaka H, Matsuki A et al. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer. Kidney Int 2004; 65: 1280-1289.
8. Dy M, Schneider E. Histamine-cytokine connection in immunity and hematopoiesis. Cytokine Growth Factor Rev 2004; 15: 393-410.
9. Packard KA, Khan MM. Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol 2003; 3: 909-920.
10. Akdis CA, Simons FE. Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 2006; 533: 69-76.
11. Gutzmer R, Diestel C, Mommert S et al. Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Immunol 2005; 174: 5224-5232.
12. Reynolds J, Albouainain A, Duda MA et al. Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat. Nephrol Dial Transplant 2006; 21: 3398-3408.
13. 4) expressed in bone marrow. Mol Pharmacol 2001; 59: 420-426.
14. Morse KL, Behan J, Laz TM et al. Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 2001; 296: 1058-1066.
15. Nguyen T, Shapiro DA, George SR et al. Discovery of a novel member of the histamine receptor family. Mol Pharmacol 2001; 59: 427-433.
16. Oda T, Morikawa N, Saito Y et al. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000; 275: 36781-36786.
17. Zhu Y, Michalovich D, Wu H et al. Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 2001; 59: 434-441.
18. Hough LB. Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol 2001; 59: 415-419.
19. Kohda T, Okada S, Hayashi A et al. High nephritogenicity of monoclonal antibodies belonging to IgG2a and IgG2b subclasses in rat anti-GBM nephritis. Kidney Int 2004; 66: 177-186.
20. + T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 2002; 109: 517-524.
21. Wu J, Hicks J, Ou C et al. Glomerulonephritis induced by recombinant collagen IVa3 chain noncollagen domain 1 is not associated with glomerular basement membrane antibody: a potential T cell-mediated mechanism. J Immunol 2001; 167: 2388-2395.
22. Wu J, Borillo J, Glass WF et al. T-cell epitope of α3 chain of type IV collagen induces severe glomerulonephritis. Kidney Int 2003; 64: 1292-1301.
23. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-146.
24. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000; 290: 92-97.
25. Adachi N, Liu K, Arai T. Prevention of brain infarction by postischemic administration of histidine in rats. Brain Res 2005; 1039: 220-223.
26. Hiraga N, Adachi N, Liu K et al. Suppression of inflammatory cell recruitment by histamine receptor stimulation in ischemic rat brains. Eur J Pharmacol 2007; 557: 236-244.
27. Motoki A, Adachi N, Semba K et al. Reduction in brain infarction by augmentation of central histaminergic activity in rats. Brain Res 2005; 1066: 172-178.
28. Janoff A. Effect of antihistamine on the increased vascular permeability induced by leukocyte lysozome fraction. Nature 1965; 212: 1605-1606.
29. Wilson CB, Gushwa LC, Peterson OW et al. Glomerular immune injury in the rat: effect of antagonists of histamine activity. Kidney Int 1981; 20: 628-635.
30. Sado Y, Kagawa M, Naito I et al. Properties of bovine nephritogenic antigen that induces anti-GBM nephritis in rats and its similarity to the Goodpasture antigen. Virchows Arch B Cell Pathol Incl Mol Pathol 1991; 60: 345-351.